Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Training and Validation Cohorts for Predicting the Impact of High Molecular Risk Mutations after Allogeneic Stem Cell Transplantation in Myelofibrosis

Blood (2022) 140 (Supplement 1): 10622–10623.

https://doi.org/10.1182/blood-2022-162298

Published: 2022

Journal Articles

Hematologic Recovery after Allogeneic Transplantation: Risk Factors and Its IMPACT on Transplant Related Mortality

Sabrina Giammarco, Carmen Di Grazia, Anna Maria Raiola, Stefania Bregante, Riccardo Varaldo, Francesca Gualandi, Simona Sica, Patrizia Chiusolo, Federica Sora, Luca Laurenti, Elisabetta Metafuni, Andrea Bacigalupo, Emanuele Angelucci

Blood (2021) 138 (Supplement 1): 2867.

https://doi.org/10.1182/blood-2021-147903

Published: 2021

Journal Articles

Bone Marrow Multiparametric Magnetic Resonance Imaging with Texture Analysis for Follow-up of Advanced Stage Myelofibrosis after Transplantation

Massimiliano Gambella, MD, Federico Zaottini, MD, Stefania Bregante, MD, Riccardo Picasso, MD, Emanuele Barabino, MD, Carlo Martinoli, MD, Emanuele Angelucci, MD

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-141099

Published: 2020

Journal Articles

Total Marrow Irradiation for Second Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Advanced Acute Leukemia

Alida Dominietto, MD, Stefano Vagge, MD, Susanta Hui, PhD, Carmen Di Grazia, MD, Teresa Lamparelli, MD, Stefania Bregante, MD, Anna Maria Raiola, MD, Riccardo Varaldo, MD, Francesca Gualandi, MD, Renzo Corvò, MD, Emanuele Angelucci, MD

Blood (2020) 136 (Supplement 1): 32.

https://doi.org/10.1182/blood-2020-140669

Published: 2020

Journal Articles

Unmanipulated Haploidentical Marrow Transplantation with a Modified Post-Transplant Cyclophosphamide (PT-CY) Regimen: An Update on 444 Patients

Andrea Bacigalupo, MD, Anna Maria Raiola, MD, Alida Dominietto, MD, Carmen Di Grazia, MD, Stefania Bregante, Francesca Gualandi, Maria Teresa Van Lint, MD, Patrizia Chiusolo, MD, Luca Laurenti, MD, Federica Sora, Sabrina Giammarco, MD PhD, Simona Sica, MD, Emanuele Angelucci, MD

Blood (2018) 132 (Supplement 1): 3351.

https://doi.org/10.1182/blood-2018-99-118850

Published: 2018

Journal Articles

The Effect of Prolonged Graft Versus Myelofibrosis May Influence the Prognosis of Patients with Myelofibrosis Relapsing after Allogenic Hematopoietic Stem Cell Transplantation: A Single Center Experience

Daniele Avenoso, Stefania Bregante, Anna Maria Raiola, MD, Riccardo Varaldo, Francesca Gualandi, Alida Dominietto, MD, Giannoni Livia, Carlo Marani, Carmen Di Grazia, MD, Teresa Lamparelli, Maria Teresa van Lint, Emanuele Angelucci

Blood (2017) 130 (Supplement 1): 5539.

https://doi.org/10.1182/blood.V130.Suppl_1.5539.5539

Published: 2017

Journal Articles

Androgens MAY BOOST Hematologic Response to ANTI-Thymocyte Globulin in Acquired Aplastic Anemia

Sabrina Giammarco, MD, Maria Teresa van Lint, MD, Teresa Lamparelli, MD, Francesca Gualandi, MD, Carmen Di Grazia, MD, Alida Dominietto, MD, Stefania Bregante, MD, Simona Sica, Andrea Bacigalupo, MD

Blood (2016) 128 (22): 3900.

https://doi.org/10.1182/blood.V128.22.3900.3900

Published: 2016

Journal Articles

PRE-Transplant Positron Emission Tomography (PET) Predicts Outcomes of Patients with Hodgkin disease Undergoing Reduced Intensity Conditioning Haploidentical Transplant

Carlo Marani, MD, Silvia Morbelli, MD, Anna Maria Raiola, MD, Alida Dominietto, MD, Giulia Ferrarazzo, MD, Sandro Nati, MD, Marina Congiu, MD, Stefania Bregante, MD, Riccardo Varaldo, MD, Francesca Gualandi, MD, Emanuele Angelucci, MD

Blood (2016) 128 (22): 3489.

https://doi.org/10.1182/blood.V128.22.3489.3489

Published: 2016

Journal Articles

Haploidentical Allogeneic Hemopoietic Stem Cell Transplant for High Risk Myelodysplastic Syndrome

Anna Maria Raiola, MD, Sara Aquino, MD, Germana Beltrami, MD, Stefania Bregante, MD, Fabio Cruciani, MD, Carmen Di Grazia, MD, Alida Dominietto, MD, Anna Ghiso, MD, Francesca Gualandi, MD, Adalberto Ibatici, MD, Teresa Lamparelli, MD, Carlo Marani, MD, Maria Teresa van Lint, MD, Riccardo Varaldo, MD, Andrea Bacigalupo, MD, Emanuele Angelucci, MD

Blood (2016) 128 (22): 3173.

https://doi.org/10.1182/blood.V128.22.3173.3173

Published: 2016

Journal Articles

The Impact of Driver Mutations of JAK2, Calr , or MPL in Patients with Myelofibrosis Undergoing Hemopoietic Stem Cell Transplantation

Andrea Bacigalupo, MD, Sarah Pozzi, Maria Teresa van Lint, MD, Stefania Bregante, Gianni Barosi, Daniela Pietra, PhD, Elisa Rumi, MD, Chiara Milanesi, Mario Cazzola, MD

Blood (2015) 126 (23): 5405.

https://doi.org/10.1182/blood.V126.23.5405.5405

Published: 2015

Journal Articles

Allogeneic Transplanst for ACUTE Myeloid Leukemia: Cut Off Levels of WT1 Expression in 207 Patients and Pre-Emptive Therapy of Relapse

Carmen Di Grazia, MD, Simona Geroldi, Raffaella Grasso, PhD, Maurizio Miglino, PhD, Nicoletta Colombo, PhD, Elisabetta Tedone, Silvia Luchetti, Teresa Lamparelli, Francesca Gualandi, MD, Adalberto Ibatici, MD, Stefania Bregante, Maria Teresa van Lint, Anna Maria Raiola, Alida Dominietto, MD, Riccardo Varaldo, Federica Galaverna, Anna Ghiso, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 1866.

https://doi.org/10.1182/blood.V126.23.1866.1866

Published: 2015

Journal Articles

Allogeneic STEM CELL Transplants for Patients with Myelofibrosis: Changes in the Transplant Platform and Improved the Outcome

Stefania Bregante, Alida Dominietto, MD, Anna Ghiso, Anna Maria Raiola, Francesca Gualandi, MD, Riccardo Varaldo, Carmen Di Grazia, MD, Teresa Lamparelli, Silvia Luchetti, Simona Geroldi, Lucia Casarino, Sarah Pozzi, Elisabetta Tedone, Maria Teresa van Lint, MD, Federica Galaverna, Gianni Barosi, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 4336.

https://doi.org/10.1182/blood.V126.23.4336.4336

Published: 2015

Journal Articles

Post-Transplant Cyclophosphamide Following a Myeloablative Conditioning For Hematologic Malignancies Receiving An Unmanipulated Haploidentical Bone Marrow Transplant

Anna Maria Raiola, Anna Ghiso, Alida Dominietto, Carmen Di Grazia, Francesca Gualandi, Riccardo Varaldo, Federica Galaverna, Maria Teresa Van Lint, Teresa Lamparelli, Stefania Bregante, Maurizio Miglino, PHD, Filippo Ballerini, PHD, Andrea Bacigalupo, MD

Blood (2013) 122 (21): 2103.

https://doi.org/10.1182/blood.V122.21.2103.2103

Published: 2013

Journal Articles

Unmanipulated Haploidentical Bone Marrow Transplantation and Post-Transplant Cyclophosphamide for Hematologic Malignanices Following A Myeloablative Conditioning.

Andrea P Bacigalupo, Anna Maria Raiola, Alida Dominietto, Maria Teresa Van Lint, MD, Francesca Gualandi, Teresa Lamparelli, Stefania Bregante, Anna Ghiso, Carmen Di Grazia, Riccardo Varaldo

Blood (2012) 120 (21): 3034.

https://doi.org/10.1182/blood.V120.21.3034.3034

Published: 2012

Journal Articles

Donor Lymphocyte Infusions (DLI) Following Haplo Bone Marrow Transplantation (hBMT) with High-Dose of Cyclophosphamide Post-Transplant As Gvhd Prophylaxis

Anna Ghiso, Annamaria Raiola, Francesca Gualandi, Alida Dominietto, Riccardo Varaldo, Maria Teresa van Lint, Stefania Bregante, Carmen Di Grazia, Teresa Lamparelli, Silvia Luchetti, Simona Geroldi, Elisabetta Tedone, Andrea P Bacigalupo

Blood (2012) 120 (21): 1950.

https://doi.org/10.1182/blood.V120.21.1950.1950

Published: 2012

Journal Articles

Rapid Immune Reconstitution Following Unmanipulated Haploidentical BMT with Post-Transplant High Dose Cyclophosphamide

Alida Dominietto, Anna Maria Raiola, Barbara Bruno, Maria Teresa van Lint, Francesco Frassoni, MD, Carmen Di Grazia, Francesca Gualandi, Stefania Bregante, Riccardo Varaldo, Anna Ghiso, Andrea Bacigalupo

Blood (2011) 118 (21): 3050.

https://doi.org/10.1182/blood.V118.21.3050.3050

Published: 2011

Journal Articles

DONOR LYMPHOCYTE INFUSIONS (DLI): Risk Factors for Non Relapse Mortality (NRM) In 287 Patients Receiving DLI

Andrea Bacigalupo, MD, Anna Maria Raiola, Alida Dominietto, Carmen Di Grazia, Francesca Gualandi, Teresa Lamparelli, Stefania Bregante, Francesco Frassoni, MD, Riccardo Varaldo, Silvana Annunziata, Maria Teresa van Lint

Blood (2010) 116 (21): 2333.

https://doi.org/10.1182/blood.V116.21.2333.2333

Published: 2010

Journal Articles

Poor Graft Function Following Allogeneic Stem Cell Transplantation: High Rate of Complete Recovery Using Boost CD34+ Selected Peripheral Blood Stem Cells without Further Conditioning.

Alessandra Larocca, MD, Barbara Bruno, Carmen Di Grazia, MD, Francesca Gualandi, MD, Domenico Occhini, MD, Anna Maria Raiola, MD, Alida Dominietto, MD, Stefania Bregante, MD, Teresa Lamparelli, MD, Maria Teresa Van Lint, MD, Enrico Maria Pogliani, MD, Andrea Bacigalupo, MD

Blood (2005) 106 (11): 5286.

https://doi.org/10.1182/blood.V106.11.5286.5286

Published: 2005

Journal Articles

Molecular Relapse of Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation Can Be Successfully Treated with Donor Lymphocyte Infusions.

Alida Dominietto, md, Anna Maria Raiola, md, Raffaella Grasso, md, Anna Garuti, md, Carmen di Grazia, md, Stefania Bregante, md, Francesca Gualandi, md, Adalberto Ibatici, md, Teresa Lamparelli, md, Maria Teresa van Lint, md, Francesco Frassoni, md, Andrea Bacigalupo, md

Blood (2004) 104 (11): 5122.

https://doi.org/10.1182/blood.V104.11.5122.5122

Published: 2004

Journal Articles

Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation

Alida Dominietto, Teresa Lamparelli, Anna Maria Raiola, Maria Teresa Van Lint, Francesca Gualandi, Giovanni Berisso, Stefania Bregante, Carmen di Grazia, Monica Soracco, Anna Pitto, Francesco Frassoni, Andrea Bacigalupo

Blood (2002) 100 (12): 3930–3934.

https://doi.org/10.1182/blood-2002-01-0339

Published: 2002

NARROW

Training and Validation Cohorts for Predicting the Impact of High Molecular Risk Mutations after Allogeneic Stem Cell Transplantation in Myelofibrosis

Hematologic Recovery after Allogeneic Transplantation: Risk Factors and Its IMPACT on Transplant Related Mortality

Bone Marrow Multiparametric Magnetic Resonance Imaging with Texture Analysis for Follow-up of Advanced Stage Myelofibrosis after Transplantation

Total Marrow Irradiation for Second Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Advanced Acute Leukemia

Unmanipulated Haploidentical Marrow Transplantation with a Modified Post-Transplant Cyclophosphamide (PT-CY) Regimen: An Update on 444 Patients

The Effect of Prolonged Graft Versus Myelofibrosis May Influence the Prognosis of Patients with Myelofibrosis Relapsing after Allogenic Hematopoietic Stem Cell Transplantation: A Single Center Experience

Androgens MAY BOOST Hematologic Response to ANTI-Thymocyte Globulin in Acquired Aplastic Anemia

PRE-Transplant Positron Emission Tomography (PET) Predicts Outcomes of Patients with Hodgkin disease Undergoing Reduced Intensity Conditioning Haploidentical Transplant

Haploidentical Allogeneic Hemopoietic Stem Cell Transplant for High Risk Myelodysplastic Syndrome

The Impact of Driver Mutations of JAK2, Calr , or MPL in Patients with Myelofibrosis Undergoing Hemopoietic Stem Cell Transplantation

Allogeneic Transplanst for ACUTE Myeloid Leukemia: Cut Off Levels of WT1 Expression in 207 Patients and Pre-Emptive Therapy of Relapse

Allogeneic STEM CELL Transplants for Patients with Myelofibrosis: Changes in the Transplant Platform and Improved the Outcome

Post-Transplant Cyclophosphamide Following a Myeloablative Conditioning For Hematologic Malignancies Receiving An Unmanipulated Haploidentical Bone Marrow Transplant

Unmanipulated Haploidentical Bone Marrow Transplantation and Post-Transplant Cyclophosphamide for Hematologic Malignanices Following A Myeloablative Conditioning.

Donor Lymphocyte Infusions (DLI) Following Haplo Bone Marrow Transplantation (hBMT) with High-Dose of Cyclophosphamide Post-Transplant As Gvhd Prophylaxis

Rapid Immune Reconstitution Following Unmanipulated Haploidentical BMT with Post-Transplant High Dose Cyclophosphamide

DONOR LYMPHOCYTE INFUSIONS (DLI): Risk Factors for Non Relapse Mortality (NRM) In 287 Patients Receiving DLI

Poor Graft Function Following Allogeneic Stem Cell Transplantation: High Rate of Complete Recovery Using Boost CD34+ Selected Peripheral Blood Stem Cells without Further Conditioning.

Molecular Relapse of Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation Can Be Successfully Treated with Donor Lymphocyte Infusions.

Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only